A Randomized Cross-over Study for Normal Pressure Hydrocephalus

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 14, 2017

Study Completion Date

September 14, 2017

Conditions
Normal Pressure Hydrocephalus
Interventions
DEVICE

MIETHKE proGAV® / MIETHKE proSA®

The programmable shunt will be adjusted through the MIETHKE proGAV® / MIETHKE proSA® valve and crossed over at 6 weeks. The open shunt will be adjusted to be closed. The closed shunt will be adjusted to open.

Trial Locations (5)

21284

Johns Hopkins University, Baltimore

23220

Virgina Commonwealth University, Richmond

43210

Ohio State University, Columbus

48202

Henry Ford Health System, Detroit

02903

Rhode Island Hospital, Providence

All Listed Sponsors
collaborator

Aesculap, Inc.

INDUSTRY

collaborator

Ohio State University

OTHER

collaborator

Rhode Island Hospital

OTHER

collaborator

Virginia Commonwealth University

OTHER

collaborator

Henry Ford Health System

OTHER

lead

Johns Hopkins University

OTHER

NCT01798641 - A Randomized Cross-over Study for Normal Pressure Hydrocephalus | Biotech Hunter | Biotech Hunter